Cis-UCA 5% emulsion cream — Competitive Intelligence Brief

Cis-UCA 5% emulsion cream (Cis-UCA 5% emulsion cream) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical corticosteroid. Area: Dermatology.

phase 2 Topical corticosteroid Dermatology Small molecule

Target snapshot

Cis-UCA 5% emulsion cream (Cis-UCA 5% emulsion cream) — BioCis Pharma Ltd. Cis-UCA 5% emulsion cream is a topical treatment that works by reducing inflammation and modulating the immune response.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Cis-UCA 5% emulsion cream TARGET	Cis-UCA 5% emulsion cream	BioCis Pharma Ltd	phase 2	Topical corticosteroid
Halobetasol Topical Lotion	Halobetasol Topical Lotion	Sun Pharmaceutical Industries Limited	marketed	Topical corticosteroid (Class I, super-potent)	Glucocorticoid receptor
Loteprednol Etabonate 0.5%	Loteprednol Etabonate 0.5%	Federal University of São Paulo	marketed	Topical corticosteroid	Glucocorticoid receptor
Enstilar® foam	Enstilar® foam	Icahn School of Medicine at Mount Sinai	marketed	Topical corticosteroid + vitamin D analog combination	Glucocorticoid receptor; vitamin D receptor (VDR)
Placebo and Triamcinolone ointment	Placebo and Triamcinolone ointment	All India Institute of Medical Sciences, Bhubaneswar	marketed	Topical corticosteroid	Glucocorticoid receptor
Hydrocortisone acetate and lidocaine hydrochloride	Hydrocortisone acetate and lidocaine hydrochloride	Citius Pharmaceuticals, Inc.	marketed	Topical corticosteroid and local anesthetic combination	Glucocorticoid receptor (hydrocortisone); voltage-gated sodium channels (lidocaine)
Clobex Spray	Clobex Spray	Galderma R&D	marketed	Topical corticosteroid (Class I/Super-potent)	Glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical corticosteroid class)

1. LEO Pharma · 3 drugs in this class
2. Pierre Fabre Medicament · 2 drugs in this class
3. GlaxoSmithKline · 2 drugs in this class
4. Promius Pharma, LLC · 2 drugs in this class
5. Astellas Pharma Inc · 1 drug in this class
6. Astion Pharma A/S · 1 drug in this class
7. Al-Azhar University · 1 drug in this class
8. BUZZZ Pharmaceuticals Limited · 1 drug in this class
9. Apotex Inc. · 1 drug in this class
10. Aswan University Hospital · 1 drug in this class